The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.
Regulation of cancer cell metabolism
Abstract
Interest in the topic of tumour metabolism has waxed and waned over the past century of cancer research. The early observations of Warburg and his contemporaries established that there are fundamental differences in the central metabolic pathways operating in malignant tissue. However, the initial hypotheses that were based on these observations proved inadequate to explain tumorigenesis, and the oncogene revolution pushed tumour metabolism to the margins of cancer research. In recent years, interest has been renewed as it has become clear that many of the signalling pathways that are affected by genetic mutations and the tumour microenvironment have a profound effect on core metabolism, making this topic once again one of the most intense areas of research in cancer biology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One possible explanation for the observed difference between cSNVs and dbSNVs could be system-wide alterations in cancer cells, which are often characterized by increased replication stress, altered DNA repair mechanisms or changes in chromatin structure (85,86).”
From G-quadruplex-mediated genomic instability drives SNVs in cancer (2024) · cites this paper as [85]
In the citing paper
“Recent findings implicate TME in the induced metabolic rewiring in cancer cells (Cairns et al., 2011; Fiaschi and Chiarugi, 2012; Rattigan et al., 2012).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Cairns et al., 2011
In the citing paper
“Unlike normal cells, which derive most of their energy from mitochondrial oxidative phosphorylation, cancer cells rely on aerobic glycolysis as their primary energy resource. This process is recognized as the “Warburg effect”21–23.”
From RETRACTED ARTICLE: Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression (2020) · cites this paper as [22]
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Stratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,625
Flagged first, then by citations
Cited by
Sorted by citations
Items 901–1,000 of 1,016
Baenke, F., Dubuis, S., Brault, C., Weigelt, B., Dankworth, B., Griffiths, B. L., Jiang, M., Mackay, A. G., Saunders, B., Spencer‐Dene, B., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4562 · Cited by 93
Compan, V., Pierredon, S., Vanderperre, B., Krznar, P., Marchiq, I., Zamboni, N., Pouysségur, J., & Martinou, J. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.06.035 · Cited by 92
Champattanachai, V., Netsirisawan, P., Chaiyawat, P., Phueaouan, T., Charoenwattanasatien, R., Chokchaichamnankit, D., Punyarit, P., Srisomsap, C., & Svasti, J. (2013) · PROTEOMICS · doi:10.1002/pmic.201200126 · Cited by 90
Solute carriers (SLCs) in cancer
El-Gebali, S., Bentz, S., Hediger, M. A., & Anderle, P. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.12.007 · Cited by 90
Novel roles of reactive oxygen species in the pathogenesis of acute myeloid leukemia
Zhou, F., Shen, Q., & Claret, F. X. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0113006 · Cited by 93
The evolution of genome-scale models of cancer metabolism
Lewis, N. E., & Abdel-Haleem, A. M. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00237 · Cited by 87
Li, G., Li, M., Hu, J., Lei, R., Xiong, H., Ji, H., Yin, H., Wei, Q., & Hu, G. (2016) · Oncogene · doi:10.1038/onc.2016.265 · Cited by 86
MicroRNAs in Tumor Cell Metabolism: Roles and Therapeutic Opportunities
Pedroza‐Torres, A., Romero-Cordoba, S. L., Justo-Garrido, M., Salido-Guadarrama, I., Rodríguez‐Bautista, R., Montaño, S., Muñiz-Mendoza, R., Arriaga-Canon, C., Fragoso‐Ontiveros, V., Álvarez-Gómez, R. M., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01404 · Cited by 93
Reactive Oxygen Species, Metabolic Plasticity, and Drug Resistance in Cancer
Bhardwaj, V., & He, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103412 · Cited by 88
Roh, J., Park, J. Y., Kim, E. H., Jang, H. J., & Kwon, M. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.11.023 · Cited by 89
Tsai, Y., Wang, C.-P., Chen, C., Lin, L., Hwang, T., Lu, L., Hsu, H., Chung, F., Lee, Y., & Houng, J. (2013) · Head & Neck · doi:10.1002/hed.23400 · Cited by 89
Huang, B., Cheng, X., Wang, D., Peng, M., Xue, Z., Da, Y., Zhang, N., Yao, Z., Li, M., Xu, A., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1963 · Cited by 89
Pancreatic tumor cell metabolism: Focus on glycolysis and its connected metabolic pathways
Guillaumond, F., Iovanna, J., & Vasseur, S. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2013.12.019 · Cited by 90
Chen, W., Lian, W., Yuan, Y., & Li, M. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1824-6 · Cited by 90
Immobilization of protein on Fe3O4 nanoparticles for magnetic hyperthermia application
Gawali, S. L., Shelar, S. B., Gupta, J., Barick, K. C., & Hassan, P. A. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.10.241 · Cited by 88
Chen, J., Wang, Y., Niu, H., Wang, Y., Wu, A., Shu, C., Zhu, Y., Bian, Y., & Lin, K. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c11032 · Cited by 89
Multi‑faceted role of cancer‑associated adipocytes in the tumor microenvironment (Review)
Yao, H., & He, S. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12506 · Cited by 92
Aurora, A. B., Khivansara, V., Leach, A., Gill, J. G., Martin-Sandoval, M. S., Yang, C., Kasitinon, S. Y., Bezwada, D., Tasdogan, A., Gu, W., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2120617119 · Cited by 88
The Potent Oxidant Anticancer Activity of Organoiridium Catalysts
Liu, Z., Romero‐Canelón, I., Qamar, B., Hearn, J. M., Habtemariam, A., Barry, N. P. E., Pizarro, A. M., Clarkson, G. J., & Sadler, P. J. (2014) · Angewandte Chemie · doi:10.1002/ange.201311161 · Cited by 90
Gupta, P., Rai, N., Verma, A. K., Saikia, D., Singh, S. P., Kumar, R., Singh, S. K., Kumar, D., & Gautam, V. (2022) · ACS Omega · doi:10.1021/acsomega.2c05605 · Cited by 88
Zinc ferrite nanoparticle-induced cytotoxicity and oxidative stress in different human cells
Alhadlaq, H. A., Akhtar, M. J., & Ahamed, M. (2015) · Cell & Bioscience · doi:10.1186/s13578-015-0046-6 · Cited by 88
Sun, K., Guo, X.-L., Zhao, Q.-D., Jing, Y.-Y., Kou, X.-R., Xie, X.-Q., Zhou, Y., Cai, N., Gao, L., Zhao, X., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.35 · Cited by 91
Gwak, H., Kim, S., Dhanasekaran, D. N., & Song, Y. S. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.11.032 · Cited by 88
Design and synthesis of emodin derivatives as novel inhibitors of ATP-citrate lyase
Koerner, S. K., Hanai, J., Bai, S., Jernigan, F. E., Oki, M., Komaba, C., Shuto, E., Sukhatme, V. P., & Sun, L. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.12.018 · Cited by 89
Lopes-Rodrigues, V., Luca, A. D., Mleczko, J., Meleady, P., Henry, M. A., Pešić, M., Cabrera, D., Liempd, S. M. V., Lima, R. T., O'Connor, R. A., et al. (2017) · Scientific Reports · doi:10.1038/srep44541 · Cited by 94
Icard, P., & Lincet, H. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.09.003 · Cited by 86
Tyszka‐Czochara, M., Bukowska-Straková, K., Kocemba‐Pilarczyk, K. A., & Majka, M. (2018) · Nutrients · doi:10.3390/nu10070841 · Cited by 89
The Expanding Role of Ketogenic Diets in Adult Neurological Disorders
McDonald, T. J. W., & Cervenka, M. C. (2018) · Brain Sciences · doi:10.3390/brainsci8080148 · Cited by 92
An, H., Guo, C., Li, D., Liu, R., Xu, X., Guo, J., Ding, J., Li, J., Chen, W., & Zhang, J. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c01413 · Cited by 87
Wu, R., Chen, X., Kang, S., Wang, T., Gnanaprakasam, J. R., Yao, Y., Liu, L., Zheng, S. G., Fan, G., Burns, M. R., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc4275 · Cited by 89
Advances and perspectives in phototherapy-based combination therapy for cancer treatment
Yi, J., Liu, L., Gao, W., Zeng, J., Chen, Y., Pang, E.-N., Lan, M., & Yu, C. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb00483c · Cited by 88
Genetically-defined metabolic reprogramming in cancer
Mullen, A. R., & DeBerardinis, R. J. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.06.009 · Cited by 90
Monitoring Dynamic Cellular Redox Homeostasis Using Fluorescence-Switchable Graphene Quantum Dots
Li, N., Than, A., Sun, C., Tian, J., Chen, J., Pu, K., Dong, X., & Chen, P. (2016) · ACS Nano · doi:10.1021/acsnano.6b07237 · Cited by 87
Thoudam, T., Jeon, J., Ha, C., & Lee, I. (2016) · Mediators of Inflammation · doi:10.1155/2016/1851420 · Cited by 91
Intracellular NAD+ depletion enhances bortezomib-induced anti-myeloma activity
Cagnetta, A., Cea, M., Calimeri, T., Acharya, C., Fulciniti, M., Tai, Y., Hideshima, T., Chauhan, D., Zhong, M. Y., Patrone, F., et al. (2013) · Blood · doi:10.1182/blood-2013-02-483511 · Cited by 86
Moore, N. F., Azarova, A. M., Bhatnagar, N., Ross, K. N., Drake, L. E., Frumm, S. M., Liu, Q. S., Christie, A. L., Sanda, T., Chesler, L., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2372 · Cited by 87
Chen, W., Zou, P., Zhao, Z., Chen, X., Fan, X., Rajamanickam, V., Cui, R., Wu, F., Zhang, Q., Liang, G., et al. (2016) · Redox Biology · doi:10.1016/j.redox.2016.09.006 · Cited by 90
Phadngam, S., Castiglioni, A., Ferraresi, A., Morani, F., Follo, C., & Isidoro, C. (2016) · Oncotarget · doi:10.18632/oncotarget.13113 · Cited by 86
Cheriyath, V., Kaur, J. S., Davenport, A., Khalel, A. F., Chowdhury, N., & Gaddipati, L. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0137-3 · Cited by 86
Fluorescent probes for visualizing ROS-associated proteins in disease
Wang, H., Wang, X., Li, P., Dong, M., Yao, S. Q., & Tang, B. (2021) · Chemical Science · doi:10.1039/d1sc02165f · Cited by 87
Targeting oxidative stress-mediated regulated cell death as a vulnerability in cancer
Chen, D., Guo, Z., Yao, L., Sun, Y., Dian, Y., Zhao, D., Ke, Y., Zeng, F., Zhang, C., Deng, G., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103686 · Cited by 95
Extracellular Flux Analysis to Monitor Glycolytic Rates and Mitochondrial Oxygen Consumption
Pelletier, M., Billingham, L. K., Ramaswamy, M., & Siegel, R. M. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-416618-9.00007-8 · Cited by 85
Drug repurposing for the treatment of glioblastoma multiforme
Abbruzzese, C., Matteoni, S., Signore, M., Cardone, L., Nath, K., Glickson, J. D., & Paggi, M. G. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0642-x · Cited by 87
Novel Oncologic Drugs: What They Do and How They Affect Images
Figueiras, R. G., Padhani, A. R., Goh, V., Vilanova, J. C., González, S. B., Martín, C. V., Gómez‐Caamaño, A., Naveira, A. B., & Choyke, P. L. (2011) · Radiographics · doi:10.1148/rg.317115108 · Cited by 85
Yuan, Y., Xu, S., Zhang, C., Zhang, R., & Liu, B. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb02270c · Cited by 85
Erdélyi, K., Ditrói, T., Johansson, H. J., Czikora, Á., Balog, N., Silwal‐Pandit, L., Ida, T., Olasz, J., Hajdú, D., Mátrai, Z., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2100050118 · Cited by 85
Mitochondrial dysfunction in cancer chemoresistance
Guaragnella, N., Giannattasio, S., & Moro, L. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.07.027 · Cited by 87
Zhang, X., Chen, M., Zou, P., Kanchana, K., Weng, Q., Chen, W., Zhong, P., Ji, J., Zhou, H., He, L., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1851-3 · Cited by 86
Dlx-2 and glutaminase upregulate epithelial-mesenchymal transition and glycolytic switch
Lee, S. Y., Jeon, H. M., Ju, M. K., Jeong, E. K., Kim, C. H., Park, H. G., Han, S. I., & Kang, H. S. (2016) · Oncotarget · doi:10.18632/oncotarget.6879 · Cited by 82
Teng, Y., Zhao, H., Gao, L., Zhang, W., Shull, A. Y., & Shay, C. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-2039 · Cited by 85
WSB1 promotes tumor metastasis by inducing pVHL degradation
Kim, J. J., Lee, S. B., Jang, J., Yi, S.-Y., Kim, S.-H., Han, S.-A., Lee, J.-M., Tong, S.-Y., Vincelette, N. D., Gao, B., et al. (2015) · Genes & Development · doi:10.1101/gad.268128.115 · Cited by 83
Monocarboxylate Transporters 1–4 in NSCLC: MCT1 Is an Independent Prognostic Marker for Survival
Eilertsen, M., Andersen, S., Al‐Saad, S., Kiselev, Y., Dønnem, T., Stenvold, H., Pettersen, I., Al-Shibli, K. I., Richardsen, E. H., Busund, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105038 · Cited by 84
Chicken or the egg: Warburg effect and mitochondrial dysfunction
Senyilmaz, D., & Teleman, A. A. (2015) · F1000Prime Reports · doi:10.12703/p7-41 · Cited by 89
Ma, F., Zhang, L., Ma, L., Zhang, Y., Zhang, J., & Guo, B. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0630-1 · Cited by 84
Cai, F., Miao, Y., Liu, C., Wu, T. H., Shen, S.-M., Su, X., & Shi, Y. P. (2017) · Oncology Letters · doi:10.3892/ol.2017.7400 · Cited by 87
Gameiro, P. A., & Struhl, K. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.021 · Cited by 91
Kulkarni, P. P., Tiwari, A., Singh, N. K., Gautam, D., Sonkar, V. K., Agarwal, V., & Dash, D. (2018) · Haematologica · doi:10.3324/haematol.2018.205724 · Cited by 85
Zhang, M., Guo, X., Wang, M., & Liu, K. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.026 · Cited by 84
Historical perspective of tumor glycolysis: A century with Otto Warburg
Bononi, G., Masoni, S., Bussolo, V. D., Tuccinardi, T., Granchi, C., & Minutolo, F. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.07.003 · Cited by 92
Excessive reactive oxygen species induce transcription-dependent replication stress
Andrš, M., Stoy, H., Boleslavska, B., Chappidi, N., Kanagaraj, R., Naščáková, Z., Menon, S., Rao, S., Oravetzova, A., Dobrovolná, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37341-y · Cited by 83
Sirtuins and the Metabolic Hurdles in Cancer
German, N. J., & Haigis, M. C. (2015) · Current Biology · doi:10.1016/j.cub.2015.05.012 · Cited by 84
SIRT6, a protein with many faces
Gertler, A. A., & Cohen, H. Y. (2013) · Biogerontology · doi:10.1007/s10522-013-9478-8 · Cited by 85
Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers
Sánchez‐Aragó, M., Formentini, L., Martínez‐Reyes, I., García‐Bermúdez, J., Santacatterina, F., Sánchez-Cenizo, L., Willers, I. M., Aldea, M., Nájera, L., Juarranz, Á., et al. (2013) · Oncogenesis · doi:10.1038/oncsis.2013.9 · Cited by 83
Targeting Mitochondrial Metabolism by Inhibiting Autophagy in BRAF-Driven Cancers
Strohecker, A. M., & White, E. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0196 · Cited by 83
Preclinical evaluation of a nanoformulated antihelminthic, niclosamide, in ovarian cancer
Lin, C.-K., Bai, M.-Y., Hu, T., Wang, Y.-C., Chao, T., Weng, S.-J., Huang, R., Su, P., & Lai, H. (2016) · Oncotarget · doi:10.18632/oncotarget.7113 · Cited by 84
Targeting of the Glutathione, Thioredoxin, and Nrf2 Antioxidant Systems in Head and Neck Cancer
Roh, J., Jang, H.-J., Kim, E. H., & Shin, D. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6841 · Cited by 84
Arif, T., Krelin, Y., Nakdimon, I., Benharroch, D., Paul, A., Dadon-Klein, D., & Shoshan‐Barmatz, V. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now297 · Cited by 86
MYC and HIF in shaping immune response and immune metabolism
Gnanaprakasam, J. R., Sherman, J. W., & Wang, R. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.03.004 · Cited by 84
Huang, Q., Stalnecker, C. A., Zhang, C., McDermott, L. A., Iyer, P. C., O’Neill, J., Reimer, S., Cerione, R. A., & Katt, W. P. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.810101 · Cited by 83
Increased Expression of PHGDH and Prognostic Significance in Colorectal Cancer
Jia, X.-Q., Zhang, S., Zhu, H., Wang, W., Zhu, J., Wang, X., & Qiang, J. (2016) · Translational Oncology · doi:10.1016/j.tranon.2016.03.006 · Cited by 85
Bioinspired Hydrogels to Engineer Cancer Microenvironments
Park, K. M., Lewis, D. M., & Gerecht, S. (2017) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071516-044619 · Cited by 85
Kobayashi, M., Morinibu, A., Koyasu, S., Gotö, Y., Hiraoka, M., & Harada, H. (2017) · FEBS Journal · doi:10.1111/febs.14280 · Cited by 82
Peng, J., Fumoto, S., Suga, T., Miyamoto, H., Kuroda, N., Kawakami, S., & Nishida, K. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.03.021 · Cited by 83
Targeting Reactive Oxygen Species in Cancer via Chinese Herbal Medicine
Qian, Q., Chen, W., Cao, Y., Cao, Q., Cui, Y., Li, Y., & Wu, J. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9240426 · Cited by 84
Mitochondrial Metabolism in Carcinogenesis and Cancer Therapy
Moindjie, H., Rodrigues, S., & Nahmias, C. (2021) · Cancers · doi:10.3390/cancers13133311 · Cited by 88
PI3K signaling-regulated metabolic reprogramming: From mechanism to application
Su, W. Y., Tian, L. Y., Guo, L. P., Huang, L., & Gao, W. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188952 · Cited by 88
Association between vitamin C intake and lung cancer: a dose-response meta-analysis
Luo, J., Li, S., & Zheng, D. (2014) · Scientific Reports · doi:10.1038/srep06161 · Cited by 83
Aberrant LPL expression, driven by STAT3, mediates free fatty acid metabolism in CLL cells
Rozovski, U., Grgurevic, S., Bueso-Ramos, C., Harris, D. M., Li, P., Liu, Z., Wu, J. Y., Jain, P., Wierda, W., Burger, J., et al. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0412 · Cited by 83
Influence of multidrug resistance and drug transport proteins on chemotherapy drug metabolism
Joyce, H., McCann, A., CLYNES, M. M., & Larkin, A. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.1028356 · Cited by 86
Liu, W., Beck, B. H., Vaidya, K. S., Nash, K. T., Feeley, K. P., Ballinger, S. W., Pounds, K. M., Denning, W. L., Diers, A. R., Landar, A. L., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1183 · Cited by 85
The Oct1 transcription factor and epithelial malignancies: Old protein learns new tricks
Vázquez-Arreguín, K., & Tantin, D. R. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.02.007 · Cited by 85
Leung, E. L., Fan, X., Wong, M. P., Jiang, Z., Liu, Z., Yao, X., Lu, L., Zhou, Y., Yau, L.-F., Tin, V. P., et al. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6420 · Cited by 84
NAD+ Kinase as a Therapeutic Target in Cancer
Tedeschi, P. M., Bansal, N., Kerrigan, J. E., Abali, E. E., Scotto, K. W., & Bertino, J. R. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1129 · Cited by 83
Murai, S., Ando, A., Ebara, S., Hirayama, M., Satomi, Y., & Hara, T. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.34 · Cited by 83
Moulder, D. E., Hatoum, D., Tay, E. S. E., Lin, Y., & McGowan, E. M. (2018) · Cancers · doi:10.3390/cancers10060189 · Cited by 87
A Metabolism Toolbox for CAR T Therapy
Xu, X., Gnanaprakasam, J. R., Sherman, J. W., & Wang, R. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00322 · Cited by 82
Activatable Singlet Oxygen Generation from Lipid Hydroperoxide Nanoparticles for Cancer Therapy
Zhou, Z., Song, J., Tian, R., Yáng, Z., Yu, G., Lin, L., Zhang, G., Fan, W., Zhang, F., Niu, G., et al. (2017) · Angewandte Chemie · doi:10.1002/ange.201701181 · Cited by 84
Targeting Cancer Cell Mitochondria as a Therapeutic Approach: Recent Updates
Cui, Q., Wen, S., & Huang, P. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0011 · Cited by 83
He, Z., Li, Z., Zhang, X., Yin, K., Wang, W., Xu, Z., Li, B., Zhang, L., Xu, J., Sun, G., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0564-3 · Cited by 82
Chen, D., Wang, H., Chen, J., Li, Z., Li, S., Hu, Z., Huang, S., Zhao, Y., & He, X. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00502 · Cited by 82
Hypoxia-active nanoparticles used in tumor theranostic
Wang, Y., Shang, W., Niu, M., Tian, J., & Xu, K. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s196959 · Cited by 85
Pascale, R. M., Simile, M. M., Calvisi, D. F., Feo, C. F., & Feo, F. (2022) · Cells · doi:10.3390/cells11030409 · Cited by 88
Zhuo, B., Li, Y., Li, Z., Qin, H., Sun, Q., Zhang, F., Shen, Y., Shi, Y., & Wang, R. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.06.092 · Cited by 82
Gwak, H., Haegeman, G., Tsang, B. K., & Song, Y. S. (2014) · Molecular Carcinogenesis · doi:10.1002/mc.22227 · Cited by 82
Kasuga, M., Ueki, K., Tajima, N., Noda, M., Ohashi, K., Noto, H., Goto, A., Ogawa, W., Sakai, R., Tsugane, S., et al. (2013) · Cancer Science · doi:10.1111/cas.12203 · Cited by 82
Dissolution DNP for in vivo preclinical studies
Comment, A. (2016) · Journal of Magnetic Resonance · doi:10.1016/j.jmr.2015.12.027 · Cited by 82
Woo, C. C., Chen, W. C., Teo, X. Q., Radda, G. K., & Lee, P. T. H. (2016) · Oncotarget · doi:10.18632/oncotarget.10415 · Cited by 81
Cruz-Gil, S., Sánchez‐Martínez, R., de Cedrón, M. G., Martín‐Hernández, R., Vargas, T., Molina, S., Herránz, J., Dávalos, A., Reglero, G., & de Molina, A. R. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m076752 · Cited by 82
Multiplicity of Steady States in Glycolysis and Shift of Metabolic State in Cultured Mammalian Cells
Mulukutla, B. C., Yongky, A., Grimm, S., Daoutidis, P., & Hu, W.-S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0121561 · Cited by 81
NOX4 supports glycolysis and promotes glutamine metabolism in non-small cell lung cancer cells
Zeng, C., Wu, Q., Wang, J., Yao, B., Ma, L., Yang, Z., Li, J., & Liu, B. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.10.500 · Cited by 81
Metadata
- Authors
- Cairns, R. A., Harris, I. S., & Mak, T. W.
- Corresponding author
- Mak, Tak W.
- Venue
- Nature Reviews Cancer
- Published
- 2011-01-24
- Volume
- 11
- Issue
- 2
- Pages
- 85-95
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2028897202
- Semantic Scholar
- 9d36b5b10983f1aa90a9d9d5a7bcffe671b38257
- Cited by
- 4,744
- References
- 142
- Citations by year
- 2026: 95 · 2025: 192 · 2024: 234 · 2023: 276 · 2022: 293 · 2021: 418 · 2020: 423 · 2019: 386 · 2018: 386 · 2017: 414 · 2016: 399 · 2015: 387 · 2014: 318 · 2013: 251 · 2012: 192
- FWCI
- 19.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Keywords
- cancer metabolism, Warburg effect, redox homeostasis, tumor microenvironment, carcinogenesis, central metabolic pathways
- MeSH terms
- Cell Transformation, Neoplastic, Humans, Neoplasms, Oxidation-Reduction, Transcription Factors, Signal Transduction, Gene Expression Regulation, Neoplastic, Intracellular Signaling Peptides and Proteins, Gene Regulatory Networks
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review